Want to join the conversation?
$COO said its unit CooperSurgical has acquired the commercial assets of Recombine, a clinical genetic testing company specializing in carrier screening. The transaction is valued at about $85MM and is expected to be neutral to EPS in FY16 and add thereafter, excluding one-time charges and deal-related amortization.
$EXTR has been on an interesting uptrend, fundamentals kinda tricky but solid technical. Earnings 5th
Wow! $MCD scores again.